Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance.

Bannerji, Rajat

Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Apr 2003 - 1466-71 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0732-183X

10.1200/JCO.2003.06.012 doi


Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
CD55 Antigens--metabolism
CD59 Antigens--metabolism
Complement System Proteins--drug effects
Drug Resistance, Neoplasm
Flow Cytometry
Gene Expression Regulation, Neoplastic
Humans
Immunoblotting
Leukemia, Lymphocytic, Chronic, B-Cell--immunology
Multicenter Studies as Topic
Myeloid Cell Leukemia Sequence 1 Protein
Neoplasm Proteins--metabolism
Proto-Oncogene Proteins--metabolism
Proto-Oncogene Proteins c-bcl-2--metabolism
Rituximab
Treatment Outcome
bcl-2-Associated X Protein